Back to search
Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD) trials you may qualify forA study to evaluate the safety and preliminary efficacy of iMSC in subjects with SR-aGVHD
The purpose of this study is to assess the efficacy and safety of ruxolitinib therapy in Chinese adults and adolescents (≥ 12 years old) with Grade II-IV steroi…
The purpose of this registration is to list Managed Access Programs (MAPs) related to INC424, Ruxolitinib
The study was an open-label, single-arm, Phase I/II multi-center study to investigate the PK, activity and safety of ruxolitinib added to the patient's immunosu…
It is a phase I/II clinical study to evaluate the safety, tolerability and preliminary efficacy of VUM02 Injection in patients with acute graft-versus-host dise…